PhaseBio Pharmaceuticals Inc (PHAS)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

1 GREAT VALLEY PARKWAY MALVERN, PA 19355

PhaseBio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The Company develops elastin-like polypeptides to increase the half-life, efficacy, and ease of administration of therapeutic drugs. PhaseBio Pharmaceuticals advances its drugs to treat endocrine, metabolic, and cardiovascular diseases.

Data based on most recent fiscal year report
Market Cap161.975 Million Shares Outstanding28.77 Million Avg Volume470.509 Thousand
1-Yr BETA vs S&P TR1.244 Current Ratio13.67 Quick Ratio13.67
View SEC Filings from PHAS instead.

View recent insider trading info

Funds Holding PHAS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PHAS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KLEIN PETER JUSTIN

  • Director
53,506 2020-04-01 1

HARRIGAN EDMUND

  • Director
664 2020-03-31 1

LOEWY CAROLINE M

  • Director
0 2020-03-13 1

HUTSON NANCY J

  • Director
59,887 2020-03-01 1

ARNOLD SUSAN ELIZABETH VP, PRECLINICAL AND CHEM

  • Officer
0 2020-02-12 1

BALLANCE DAVID JAMES VP, RESEARCH AND SCI. AFFAIRS

  • Officer
0 2020-02-12 1

LEE JOHN SANG CHIEF MEDICAL OFFICER

  • Officer
0 2020-02-12 1

MOW JONATHAN P CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2020-02-12 3

SHARP JOHN P CHIEF FINANCIAL OFFICER

  • Officer
0 2020-02-12 3

YORK MICHAEL VP, CORPORATE DEVELOPMENT

  • Officer
0 2020-02-12 1

HANSON KRISTOPHER VP, HEAD OF LEGAL

  • Officer
0 2020-02-12 3

SAPIR ALEX

  • Director
0 2020-02-12 2

BURKHARDT GLEN VP, HUMAN RESOURCES

  • Officer
0 2020-02-12 2

THORP CLAY

  • Director
  • 10% Owner
4,992,420 2019-11-22 3

RIVERS TYRELL

  • Director
0 2019-10-02 0

MUKHOPADHYAY BIBHASH

  • Director
0 2019-05-09 1

VAN DEN BROEK RICHARD

  • Director
0 2019-05-09 1

TUFTS LINDA

  • Director
0 2019-02-27 0

ASTRAZENECA PLC

ZENECA, INC.

  • 10% Owner
3,004,554 2018-10-22 0

HATTERAS VENTURE ADVISORS III, LLC

HATTERAS VENTURES PARTNERS III LP

HATTERAS VENTURE AFFILIATES III LP

HATTERAS VENTURE PARTNERS I, LP

CATALYSTA VENTURES, LLC

VENTURE CAPITAL MULTIPLIER FUND

INGRAM ROBERT ALEXANDER

LEE KENNETH B JR

REED DOUGLAS MD

CRUMPLER JOHN

  • 10% Owner
2,458,049 2018-10-22 0

NEW ENTERPRISE ASSOCIATES 13 LP

NEA PARTNERS 13, LIMITED PARTNERSHIP

NEA 13 GP, LTD

BARRETT M JAMES

BARRIS PETER J

BASKETT FOREST

KERINS PATRICK J

MOTT DAVID M

SANDELL SCOTT D

VISWANATHAN RAVI

  • 10% Owner
6,641,634 2018-10-22 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

ARNOLD SUSAN ELIZABETH - Officer VP, PRECLINICAL AND CHEM

2020-02-12 A 55,000 a 55,000 0.00 direct

MOW JONATHAN P - Director - Officer CHIEF EXECUTIVE OFFICER

2020-02-12 A 290,000 a 290,000 0.00 direct

YORK MICHAEL - Officer VP, CORPORATE DEVELOPMENT

2020-02-12 A 55,000 a 55,000 0.00 direct

SAPIR ALEX - Director

2020-02-12 A 32,000 a 32,000 0.00 direct

BURKHARDT GLEN - Officer VP, HUMAN RESOURCES

2020-02-12 A 20,000 a 20,000 0.00 direct

SHARP JOHN P - Officer CHIEF FINANCIAL OFFICER

2020-02-12 A 100,000 a 100,000 0.00 direct

LEE JOHN SANG - Officer CHIEF MEDICAL OFFICER

2020-02-12 A 100,000 a 100,000 0.00 direct

BALLANCE DAVID JAMES - Officer VP, RESEARCH AND SCI. AFFAIRS

2020-02-12 A 55,000 a 55,000 0.00 direct

BURKHARDT GLEN - Officer VP, HUMAN RESOURCES

2020-02-12 A 55,000 a 55,000 0.00 direct

HANSON KRISTOPHER - Officer VP, HEAD OF LEGAL

2020-02-12 A 55,000 a 55,000 0.00 direct

**EXPERIMENTAL** Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin
Squarepoint Ops LLC PhaseBio Pharmaceuticals Inc 0.5% 2020-02-20 GERMANY

Short Position History

Holder Net Short Position Position Date Origin

Elevate your investments